A Novel Microspheres Formulation of Puerarin: Pharmacokinetics Study and In Vivo Pharmacodynamics Evaluations
Open Access
- 1 January 2016
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2016 (1) , 4016963
Abstract
The aim of this study was to investigate the pharmacokinetics and pharmacodynamics of puerarin loaded carboxymethyl chitosan microspheres (Pue‐CCMs). The differences in pharmacokinetics parameters of rats after intragastric administration of Pue‐CCMs and puerarin were investigated using HPLC. To assess the protective effect of Pue‐CCMs on myocardial injury in rats, serum levels of creatine kinase (CK), lactate dehydrogenase (LDH), total superoxide dismutase (T‐SOD), and malondialdehyde (MDA) were measured, in addition to pathological examinations and immunohistochemical staining. Our present study has shown that the AUC0–t, Cmax, Tmax, MRT0–t of Pue‐CCMs, and puerarin were 20.176 mg·h/L, 3.778 μg/mL, 1 h, 4.634 h and 9.474 mg·h/L, 2.618 μg/mL, 0.542 h, and 3.241 h, respectively. Pue‐CCMs alleviated myocardial ischemic injury. Pretreatment with Pue‐CCMs could significantly decrease CK, LDH, and MDA levels and increase T‐SOD level in the serum. Pue‐CCMs downregulated expression of the Bcl‐2 associated X protein (Bax) and upregulated B‐cell lymphoma‐2 (Bcl‐2) expression. Compared with puerarin group, the Pue‐CCMs group could improve the oral bioavailability of puerarin. The protective effect of Pue‐CCMs against myocardial injury was significantly greater than puerarin at the same dose. In summary, Pue‐CCMs should be a qualified and promising candidate as a new oral preparation of puerarin.Keywords
Funding Information
- National Natural Science Foundation of China (81373944, 2012KTCQ03-13)
This publication has 20 references indexed in Scilit:
- Puerarin inhibits the inflammatory response in atherosclerosis via modulation of the NF-κB pathway in a rabbit modelPharmacological Reports, 2016
- Cardioprotective effect of total saponins from three medicinal species of Dioscorea against isoprenaline-induced myocardial ischemiaJournal of Ethnopharmacology, 2015
- The construction of puerarin nanocrystals and its pharmacokinetic and in vivo–in vitro correlation (IVIVC) studies on beagle dogColloids and Surfaces B: Biointerfaces, 2015
- Simultaneous determination of acetylpuerarin and puerarin in rat plasma by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study following intravenous and oral administrationJournal of Chromatography B, 2015
- Protective effects of puerarin against Aß40-induced vascular dysfunction in zebrafish and human endothelial cellsEuropean Journal of Pharmacology, 2014
- Biopharmaceutics classification of puerarin and comparison of perfusion approaches in ratsInternational Journal of Pharmaceutics, 2014
- Simultaneous determination of gastrodin and puerarin in rat plasma by HPLC and the application to their interaction on pharmacokineticsJournal of Chromatography B, 2013
- In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicityInternational Journal of Pharmaceutics, 2013
- Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral deliveryInternational Journal of Pharmaceutics, 2012
- Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administrationInternational Journal of Pharmaceutics, 2011